Figure 2: TRITON-TIMI 38 — composite and component event rates (prasugrel vs clopidogrel)

Event rates by composite component in TRITON-TIMI 38 (median follow-up 14.5 months). Source: Wiviott SD et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001-15.
Chart: Letters from a PharmacistGet the dataCreated with Datawrapper